The Michigan Department of Health and Human Services (MDHHS) is recommending that healthcare providers across the state partner with NxGen MDx in order to maximize the availability of COVID-19 testing.
| GRAND RAPIDS, Mich., April 22, 2020 /PRNewswire/ -- The Michigan Department of Health and Human Services (MDHHS) is recommending that healthcare providers across the state partner with NxGen MDx in order to maximize the availability of COVID-19 testing. With the ability to test for 7000 samples per week, NxGen MDx is also able to provide specimen collection materials, shipping from the collection site to their laboratory, and 48-hour turnaround on results. NxGen has validated their testing using an endocervical swab rather than a nasopharyngeal swab; while the swabs have very similar shapes and clinical uses, endocervical swabs have a large and steady supply chain, while access to nasopharyngeal swabs is unfortunately very constrained. According to MDHHS, capacity for COVID-19 testing will need to triple or quadruple in Michigan in order to protect public health. Especially with the recent expansion in test priority criteria, maximizing the use of all available testing capacity is crucial. MDHHS strongly encourages health care providers interested in COVID-19 testing to reach out to NxGen Laboratories as a potential partner. About NxGen MDx Connect with us on:
SOURCE NxGen MDx |
View original content:
